An evaluation of the feasibility of implementing a novel tobacco dependence treatment program for high-risk individuals into clinical practice within a community mental health center.
Community mental health centers
Feasibility
Health care professionals
Implementation science
Mental health
Psychotic-spectrum disorders
Qualitative study
Schizophrenia
Tobacco cessation
Tobacco treatment
Journal
International journal of mental health systems
ISSN: 1752-4458
Titre abrégé: Int J Ment Health Syst
Pays: England
ID NLM: 101294224
Informations de publication
Date de publication:
20 Feb 2022
20 Feb 2022
Historique:
received:
11
05
2021
accepted:
13
01
2022
entrez:
21
2
2022
pubmed:
22
2
2022
medline:
22
2
2022
Statut:
epublish
Résumé
Individuals with serious mental illnesses experience deaths related to smoking at a higher prevalence than individuals without a psychotic-spectrum disorders. Traditional smoking cessation programs are often not effective among individuals with chronic mental disorders. Little is known about how to implement a tobacco cessation treatment program for this at-risk population within a community health center. The current study used qualitative methods to examine the factors that may enhance or impede the delivery of a novel tobacco cessation treatment for smokers with a psychotic-spectrum disorder diagnosis in an integrated care community health center. Using a case study design, we conducted 22 semi-structured interviews with primary care providers, mental health providers, addiction counselors, case managers, intake specialists, schedulers, pharmacists, and administrative staff employed at the organization. Interviews were transcribed and themes were identified through a rich coding process. We identified environmental factors, organizational factors, provider factors and patient factors which describe the potential factors that may enhance or impede the implementation of a smoking cessation program at the integrated care community health center. Most notably, we identified that community mental health centers looking to implement a smoking cessation program for individuals with chronic mental health disorders should ensure the incentives for providers to participate align with the program's objectives. Additionally, organizations should invest in educating providers to address stigma related to smoking cessation and nicotine use. The findings of our study provide valuable insight for administrators to consider when implementing a smoking cessation program in an integrated care community health center. Our findings provide public health practitioners with potential considerations that should be discussed when designing and implementing a smoking cessation program for individuals with chronic mental disorders.
Sections du résumé
BACKGROUND
BACKGROUND
Individuals with serious mental illnesses experience deaths related to smoking at a higher prevalence than individuals without a psychotic-spectrum disorders. Traditional smoking cessation programs are often not effective among individuals with chronic mental disorders. Little is known about how to implement a tobacco cessation treatment program for this at-risk population within a community health center. The current study used qualitative methods to examine the factors that may enhance or impede the delivery of a novel tobacco cessation treatment for smokers with a psychotic-spectrum disorder diagnosis in an integrated care community health center.
METHODS
METHODS
Using a case study design, we conducted 22 semi-structured interviews with primary care providers, mental health providers, addiction counselors, case managers, intake specialists, schedulers, pharmacists, and administrative staff employed at the organization. Interviews were transcribed and themes were identified through a rich coding process.
RESULTS
RESULTS
We identified environmental factors, organizational factors, provider factors and patient factors which describe the potential factors that may enhance or impede the implementation of a smoking cessation program at the integrated care community health center. Most notably, we identified that community mental health centers looking to implement a smoking cessation program for individuals with chronic mental health disorders should ensure the incentives for providers to participate align with the program's objectives. Additionally, organizations should invest in educating providers to address stigma related to smoking cessation and nicotine use.
CONCLUSIONS
CONCLUSIONS
The findings of our study provide valuable insight for administrators to consider when implementing a smoking cessation program in an integrated care community health center. Our findings provide public health practitioners with potential considerations that should be discussed when designing and implementing a smoking cessation program for individuals with chronic mental disorders.
Identifiants
pubmed: 35184758
doi: 10.1186/s13033-022-00517-y
pii: 10.1186/s13033-022-00517-y
pmc: PMC8858522
doi:
Types de publication
Journal Article
Langues
eng
Pagination
15Subventions
Organisme : Ohio Department of Health
ID : CSP904017-01
Informations de copyright
© 2022. The Author(s).
Références
J Addict Med. 2014 Jan-Feb;8(1):59-65
pubmed: 24365803
J Psychiatr Res. 2014 Jan;48(1):102-10
pubmed: 24139811
Psychiatr Serv. 2014 Jan 1;65(1):75-80
pubmed: 23999796
N Engl J Med. 2011 Jul 21;365(3):196-8
pubmed: 21774707
Cochrane Database Syst Rev. 2013 Feb 28;(2):CD007253
pubmed: 23450574
BMC Psychol. 2014 Oct 10;2(1):41
pubmed: 25566387
J Dual Diagn. 2015;11(2):145-50
pubmed: 25985201
Pediatrics. 2015 Jan;135(1):e43-51
pubmed: 25511118
Nicotine Tob Res. 2018 Sep 4;20(10):1223-1230
pubmed: 29059344
Int J Ment Health Syst. 2010 Jul 28;4:23
pubmed: 20667105
Schizophr Bull. 1998;24(2):189-202
pubmed: 9613620
Harv Rev Psychiatry. 2015 Mar-Apr;23(2):90-8
pubmed: 25747922
Early Interv Psychiatry. 2017 Jun;11(3):244-249
pubmed: 26472632
Arch Gen Psychiatry. 2007 Oct;64(10):1123-31
pubmed: 17909124
J Smok Cessat. 2021 Jul 27;2021:6617716
pubmed: 34429783
Adm Policy Ment Health. 2012 Sep;39(5):353-64
pubmed: 21574016
Neurosci Biobehav Rev. 2005;29(6):1021-34
pubmed: 15964073
Addiction. 2016 Sep;111(9):1536-53
pubmed: 27003925
Int Clin Psychopharmacol. 2002 May;17(3):141-3
pubmed: 11981356
Patient Educ Couns. 2009 Nov;77(2):289-95
pubmed: 19398293
Pharmacol Biochem Behav. 2001 Dec;70(4):561-70
pubmed: 11796154
Psychiatr Serv. 2013 Jan;64(1):44-50
pubmed: 23280457
Psychol Addict Behav. 2013 Mar;27(1):249-55
pubmed: 22642854
Adm Policy Ment Health. 2015 Sep;42(5):533-44
pubmed: 24193818
Schizophr Res. 2005 Jul 15;76(2-3):135-57
pubmed: 15949648
J Subst Abuse Treat. 2007 Jan;32(1):53-60
pubmed: 17175398
Am J Public Health. 2010 Dec;100(12):2464-72
pubmed: 20966369
Early Interv Psychiatry. 2021 Sep 7;:
pubmed: 34494357